Disparities in Breast Cancer
- PMID: 35168767
- DOI: 10.1016/j.ogc.2021.11.010
Disparities in Breast Cancer
Abstract
In the western world, breast cancer is the most common lethal cancer in women and the second leading cause of cancer death behind lung cancer. When assessing registry data, incidence and mortalty vary significantly by race or ethnicity and by socioeconomic status. There are a number of established risk factors, that effect risk of not just risk of breast cancer overall but the risk of certain molecular subtypes of breast cancer. Other factors in the disparity in outcomes include certain populations experiencing lower quality of care; prevention, screening, diagnosis and treatment.
Keywords: breast cancer; breast cancer disparities; epidemiology of breast cancer; risk factors for breast cancer; risk reduction of breast cancer.
Copyright © 2022 Elsevier Inc. All rights reserved.
Similar articles
-
Trends in area-socioeconomic and race-ethnic disparities in breast cancer incidence, stage at diagnosis, screening, mortality, and survival among women ages 50 years and over (1987-2005).Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):121-31. doi: 10.1158/1055-9965.EPI-08-0679. Cancer Epidemiol Biomarkers Prev. 2009. PMID: 19124489
-
Disparities in race/ethnicity and socioeconomic status: risk of mortality of breast cancer patients in the California Cancer Registry, 2000-2010.BMC Cancer. 2013 Oct 2;13:449. doi: 10.1186/1471-2407-13-449. BMC Cancer. 2013. PMID: 24083624 Free PMC article.
-
Health disparities across the breast cancer continuum.Semin Oncol Nurs. 2015 May;31(2):170-7. doi: 10.1016/j.soncn.2015.02.005. Epub 2015 Feb 16. Semin Oncol Nurs. 2015. PMID: 25951746 Free PMC article. Review.
-
Socioeconomic factors and breast carcinoma in multicultural women.Cancer. 2000 Mar 1;88(5 Suppl):1256-64. doi: 10.1002/(sici)1097-0142(20000301)88:5+<1256::aid-cncr13>3.0.co;2-3. Cancer. 2000. PMID: 10705364 Review.
-
Inequalities in health? An update on the effect of social deprivation for patients with breast cancer in South East Wales.Surgeon. 2019 Apr;17(2):88-96. doi: 10.1016/j.surge.2018.05.004. Epub 2018 Jun 20. Surgeon. 2019. PMID: 29936016
Cited by
-
Trends in breast cancer screening during the COVID-19 pandemic within a universally insured health system in the United States, 2017-2022.Cancer Med. 2023 Sep;12(18):19126-19136. doi: 10.1002/cam4.6487. Epub 2023 Aug 28. Cancer Med. 2023. PMID: 37641528 Free PMC article.
-
Targeting triple negative breast cancer stem cells using nanocarriers.Discov Nano. 2024 Mar 7;19(1):41. doi: 10.1186/s11671-024-03985-y. Discov Nano. 2024. PMID: 38453756 Free PMC article. Review.
-
The combination of hydroxychloroquine and 2-deoxyglucose enhances apoptosis in breast cancer cells by blocking protective autophagy and sustaining endoplasmic reticulum stress.Cell Death Discov. 2022 Jun 11;8(1):286. doi: 10.1038/s41420-022-01074-6. Cell Death Discov. 2022. PMID: 35690609 Free PMC article.
-
Metabolomic Profiling of Disease Progression Following Radiotherapy for Breast Cancer.Cancers (Basel). 2025 Mar 5;17(5):891. doi: 10.3390/cancers17050891. Cancers (Basel). 2025. PMID: 40075737 Free PMC article.
-
The value of nanocarbon contrast methylene blue based on dye-based tracer technology in sentinel lymph node biopsy for breast cancer: a systematic review and meta-analysis.PeerJ. 2025 Jun 11;13:e19546. doi: 10.7717/peerj.19546. eCollection 2025. PeerJ. 2025. PMID: 40520631 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical